Cvs Pharamcy # 02795 Durable Medical Equipment & Medical Supplies Location: 317 Central Ave, East Orange, New Jersey 07018 Phone: (973) 678-7020 |
Rite Aid Pharmacy 03697 Durable Medical Equipment & Medical Supplies Location: 543 Central Ave, East Orange, New Jersey 07018 Phone: (973) 677-7880 |
Walgreens #06162 Durable Medical Equipment & Medical Supplies Location: 508 Martin Luther King Jr Blvd, East Orange, New Jersey 07018 Phone: (973) 672-6317 |
Sheefa Pharmacy & Wellness Center Durable Medical Equipment & Medical Supplies Location: 405 Central Ave, East Orange, New Jersey 07018 Phone: (973) 673-6800 |
Rite Care Pharmacy Durable Medical Equipment & Medical Supplies Location: 630 Central Ave, East Orange, New Jersey 07018 Phone: (973) 676-5959 |
East Orange Pharmacy & Surgicals Community/Retail Pharmacy Location: 310 Central Ave, East Orange, New Jersey 07018 Phone: (973) 674-5777 |
Washington Shop Pharmacy Long Term Care Pharmacy Location: 90 Washington St, East Orange, New Jersey 07017 Phone: (973) 676-0800 |
Walgreens#19519 Durable Medical Equipment & Medical Supplies Location: 80 Central Ave, East Orange, New Jersey 07018 Phone: (973) 672-8232 |
Metro Installations Mobilty Provide Durable Medical Equipment & Medical Supplies Location: 146 Brighton Avenue, East Orange, New Jersey 07017 Phone: (862) 520-1653 |
Dr Winston Scott Medicare Supplier Location: 310 Central Ave, East Orange, New Jersey 07018 Phone: (973) 674-1070 |
News Archive
Biogen Idec announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a negative opinion recommending against approval of FAMPYRA to improve walking ability in adult patients with multiple sclerosis (MS) in the European Union. Biogen Idec intends to appeal this opinion and request a re-examination of the decision by the CHMP.
Increasing vitamin D levels may lower risk for developing cancer, according to a study conducted by Creighton University with cooperation from the University of California San Diego.
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences. Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.
› Verified 7 days ago